Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Pietsch, Carsten; de Galiza Barbosa, Felipe; Hüllner, Martin W; Schmid, Daniel T; Haerle, Stephan K; Huber, Gerhard F; Studer, Gabriela; Hany, Thomas F; Veit-Haibach, Patrick (2015). Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study. BMC Medical Imaging, 15(1):60-69.

Sah, Bert-Ram; Burger, Irene A; Schibli, Roger; Friebe, Matthias; Dinkelborg, Ludger; Graham, Keith; Borkowski, Sandra; Bacher-Stier, Claudia; Valencia, Ray; Srinivasan, Ananth; Hany, Thomas F; Mu, Linjing; Wild, Peter J; Schaefer, Niklaus G (2015). Dosimetry and First Clinical Evaluation of the New 18F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer. Journal of Nuclear Medicine, 56(3):372-378.

Burger, Irene A; Zitzmann-Kolbe, Sabine; Pruim, Jan; Friebe, Matthias; Graham, Keith; Stephens, Andrew; Dinkelborg, Ludger; Kowal, Kristin; Schibli, Roger; Luurtsema, Gert; Maas, Bram; Horn-Tutic, Michaela; Haerle, Stephan K; Wiegers, Johan; Schaefer, Niklaus G; Hany, Thomas F; von Schulthess, Gustav K (2014). First Clinical Results of (d)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma. Journal of Nuclear Medicine, 55(11):1778-1785.

Fischer, Michael A; Vrugt, Bart; Alkadhi, Hatem; Hahnloser, Dieter; Hany, Thomas F; Veit-Haibach, Patrick (2014). Integrated (18)F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology. European Journal of Nuclear Medicine and Molecular Imaging, 41(8):1563-1573.

Burger, Irene A; Schwarz, Esther I; Samarin, Andrei; Breitenstein, Stefan; Weber, Achim; Hany, Thomas F (2013). Correlation between therapy response assessment using FDG PET/CT and histopathologic tumor regression grade in hepatic metastasis of colorectal carcinoma after neoadjuvant therapy. Annals of Nuclear Medicine, 27(2):177-183.

Haerle, Stephan K; Hany, Thomas F; Ahmad, Nader; Burger, Irene; Huber, Gerhard F; Schmid, Daniel T (2013). Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake? Cancer Imaging, 13(1):1-7.

Soyka, Jan D; Muster, Marco A; Schmid, Daniel T; Seifert, Burkhardt; Schick, Ulrike; Miralbell, Raymond; Jorcano, Sandra; Zaugg, Kathrin; Seifert, Hans-Helge; Veit-Haibach, Patrick; Strobel, Klaus; Schaefer, Niklaus G; Husarik, Daniela B; Hany, Thomas F (2012). Clinical impact of (18)F-choline PET/CT in patients with recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 39(6):936-943.

Rothschild, Sacha; Studer, Gabriela; Seifert, Burkhardt; Huguenin, Pia; Glanzmann, Christoph; Davis, J Bernard; Lütolf, Urs M; Hany, Thomas F; Ciernik, I Frank (2007). PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison. Radiation Oncology, 2:22.

Petrowsky, Henrik; Wildbrett, Peer; Husarik, Daniela B; Hany, Thomas F; Tam, Simona; Jochum, Wolfram; Clavien, Pierre-Alain (2006). Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. Journal of Hepatology, 45(1):43-50.

Goerres, Gerhard W; Kamel, Ehab; Seifert, Burkhardt; Burger, Cyrill; Buck, Alfred; Hany, Thomas F; Von Schulthess, Gustav K (2002). Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. Journal of Nuclear Medicine, 43(11):1469-1475.

This list was generated on Sun Nov 19 05:22:07 2017 CET.